Viva Biotech Holdings’ US$180 Million Convertible Bonds Issuance

Sidley Austin LLP advised Viva Biotech Holdings on the transaction.

Viva Biotech Holdings (HKEX: 1873) has successfully issued US$180 million of guaranteed convertible bonds due 2025 through its wholly owned subsidiary, Viva Incubator Investment Management Limited. J.P. Morgan Securities, The Hongkong and Shanghai Banking Corporation Limited and China International Capital Corporation Hong Kong Securities Limited are the underwriters in this transaction.

Viva Biotech is a leading open-access and innovation-driven technology platform company, and has become a cradle for promising biotechnology companies through its innovative and unique business model.

The Sidley team was led by partners Mengyu Lu (Picture), Oliver Zhong and Carrie Li, with support from associate Jacob Zhao, legal managers Ashlee Wu and Paul Qu, senior legal assistant Grace Qiao and legal assistant Kaiwen Xu.

Involved fees earner: Carrie Li – Sidley Austin LLP; Mengyu Lu – Sidley Austin LLP; Jacob Zhao – Sidley Austin LLP; Oliver Zhong – Sidley Austin LLP;

Law Firms: Sidley Austin LLP;

Clients: Viva Biotech Holdings;